LRPA
BMY icon

L. Roy Papp & Associates’s Bristol-Myers Squibb BMY Stock Holding History

L. Roy Papp & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Hold
8,252
– – 0.05% 138
2026
Q1 		$500K Buy
8,252
+76
+0.9% +$4.43K 0.06% 128
2025
Q4 		$441K Hold
8,176
– – 0.05% 139
2025
Q3 		$369K Sell
8,176
-500
-6% -$23.4K 0.04% 142
2025
Q2 		$402K Hold
8,676
– – 0.05% 136
2025
Q1 		$529K Sell
8,676
-1,408
-14% -$82.1K 0.06% 124
2024
Q4 		$570K Hold
10,084
– – 0.07% 120
2024
Q3 		$522K Sell
10,084
-1,100
-10% -$51.6K 0.06% 121
2024
Q2 		$464K Hold
11,184
– – 0.06% 126
2024
Q1 		$607K Hold
11,184
– – 0.07% 113
2023
Q4 		$574K Hold
11,184
– – 0.07% 113
2023
Q3 		$649K Hold
11,184
– – 0.09% 105
2023
Q2 		$715K Hold
11,184
– – 0.09% 107
2023
Q1 		$775K Hold
11,184
– – 0.1% 107
2022
Q4 		$805K Sell
11,184
-108
-1% -$8.14K 0.11% 105
2022
Q3 		$803K Sell
11,292
-6,696
-37% -$486K 0.12% 102
2022
Q2 		$1.39M Buy
17,988
+108
+0.6% +$8.22K 0.2% 80
2022
Q1 		$1.31M Buy
17,880
+988
+6% +$66.3K 0.16% 88
2021
Q4 		$1.05M Buy
16,892
+20
+0.1% +$1.17K 0.12% 97
2021
Q3 		$998K Sell
16,872
-200
-1% -$13.2K 0.13% 95
2021
Q2 		$1.14M Buy
17,072
+1,200
+8% +$78.2K 0.14% 92
2021
Q1 		$1M Sell
15,872
-1,229
-7% -$76.5K 0.14% 88
2020
Q4 		$1.06M Sell
17,101
-2,991
-15% -$184K 0.12% 96
2020
Q3 		$1.21M Sell
20,092
-890
-4% -$53.6K 0.16% 86
2020
Q2 		$1.23M Buy
20,982
+9
+0% +$538 0.17% 87
2020
Q1 		$1.17M Buy
20,973
+65
+0.3% +$3.97K 0.21% 84
2019
Q4 		$1.34M Buy
20,908
+16,973
+431% +$972K 0.19% 87
2019
Q3 		$200K Buy
+3,935
New +$185K 0.03% 170
2019
Q2 		– Sell
-6,235
Closed -$297K – 174
2019
Q1 		$297K Hold
6,235
– – 0.05% 128
2018
Q4 		$324K Hold
6,235
– – 0.07% 120
2018
Q3 		$387K Sell
6,235
-528
-8% -$31.3K 0.07% 122
2018
Q2 		$374K Sell
6,763
-798
-11% -$43.1K 0.07% 122
2018
Q1 		$478K Buy
7,561
+609
+9% +$39.2K 0.09% 114
2017
Q4 		$426K Buy
6,952
+43
+0.6% +$2.69K 0.08% 114
2017
Q3 		$440K Buy
6,909
+9
+0.1% +$526 0.1% 101
2017
Q2 		$384K Buy
6,900
+1,300
+23% +$70.7K 0.08% 118
2017
Q1 		$305K Hold
5,600
– – 0.07% 112
2016
Q4 		$327K Buy
5,600
+700
+14% +$38.3K 0.07% 125
2016
Q3 		$264K Buy
4,900
+1,700
+53% +$109K 0.06% 127
2016
Q2 		$235K Hold
3,200
– – 0.06% 139
2016
Q1 		$204K Sell
3,200
-55
-2% -$3.47K 0.05% 144
2015
Q4 		$224K Buy
+3,255
New +$215K 0.05% 130

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

L. Roy Papp & Associates's BMY Position: Q2 2026 in Review

L. Roy Papp & Associates held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 8,252 shares worth $475K. The position accounts for 0.05% of the portfolio, ranked #138.

L. Roy Papp & Associates first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.39M in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • L. Roy Papp & Associates held 8,252 shares of Bristol-Myers Squibb worth $475K as of Q2 2026.
  • L. Roy Papp & Associates left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.05% of L. Roy Papp & Associates's portfolio in Q2 2026, its #138 holding.
  • L. Roy Papp & Associates first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
  • L. Roy Papp & Associates's Bristol-Myers Squibb position peaked at $1.39M in Q2 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.